Clinical Trial Laboratory Services
Comprehensive laboratory support for all phases of clinical trials.
Biomarker-driven trial design and testing add complexity to the drug development process, with laboratory support required at every phase. Covance is committed to helping you navigate the process, providing comprehensive scientific and medical support to complement your drug development program. Covance clinical trial laboratory services include:
- Core central laboratory testing with globally combinable data
- Preclinical and clinical bioanalytical testing
- Specialty testing – such as genomics, flow cytometry, or anatomic pathology and histology
Our job is to translate extensive experience into insights that will make a difference when partnering to deliver your studies.
Support for your clinical trial, regardless of trial size, comes from five globally integrated central labs located strategically around the world. With both automation and streamlined processes guided by uniform procedures that minimize variability, your lab data is of the highest quality -- consistent and globally-combinable.
Precision Medicine has revolutionized how physicians diagnose and treat patients. Covance offers a broad array of precision medicine services – including state-of-the art technology, biomarker and clinical trial design consultation, and deep expertise in cell and gene therapies and companion diagnostic co-development – to help you discover, develop and commercialize your next advanced therapy.
Avoid potential risk in your development with a centralized Chemistry, Manufacturing and Control (CMC) analytical testing approach for your drug substance/ drug product, preserving consistent quality and continuity of data. Access specialized scientific expertise from four GMP analytical development sites across the U.S. and U.K. with dedicated project management to support your full product lifecycle.
Working as an extension of your team, our dedicated scientists can serve as your partner from lead optimization to commercialization.
Anticipate regulatory challenges and develop strategic solutions across the drug development continuum – from discovery to clinical development – with global expertise in biologics and small molecule bioanalytical services. Eight global sites offer experience across multiple species and matrices supporting preclinical PK/TK, clinical PK/bioavailability, bioequivalence, therapeutic drug monitoring, drug-drug interaction, and pharmacodynamic studies.